European Journal of Gynaecological Oncology
Print ISSN: 0392-2936 | Online ISSN: 2709-0086
European Journal of Gynaecological Oncology (EJGO) is an international, peer-reviewed, open access journal. EJGO publishes on a broad range of gynaecologic oncology topics. Different types of articles are considered for publication (see Aims & Scope) with emphasis on original research to include prospective clinical trials, basic and applied science, case-control, and cohort studies. We also encourage the submission of systematic reviews and meta-analyses.
Articles
The complex clinical challenges of secondary ovarian tumors and cancer of unknown primary: diagnostic and therapeutic considerations
The complex clinical challenges of secondary ovarian tumors and cancer of unknown primary: diagnostic and therapeutic considerations
DOI: 10.22514/ejgo.2025.016
Cervical conization in women of reproductive age from patient's perspective: how much do we know?
Cervical conization in women of reproductive age from patient's perspective: how much do we know?
DOI: 10.22514/ejgo.2025.017
Development of a novel web-based calculator for predicting overall survival in early-onset cervical cancer patients with positive lymph node metastasis
Development of a novel web-based calculator for predicting overall survival in early-onset cervical cancer patients with positive lymph node metastasis
DOI: 10.22514/ejgo.2025.018
Succinic acid might be an inducement for the road to RIPK for death through necroptosis in endometrium cancer
Succinic acid might be an inducement for the road to RIPK for death through necroptosis in endometrium cancer
DOI: 10.22514/ejgo.2025.019
Expression and clinical significance of osteocalcin in endometrial carcinoma
Expression and clinical significance of osteocalcin in endometrial carcinoma
DOI: 10.22514/ejgo.2025.020
Identification of an immune-related metabolic gene signature to predict possible prognosis in endometrial cancer and reveals immune landscape feature
Identification of an immune-related metabolic gene signature to predict possible prognosis in endometrial cancer and reveals immune landscape feature
DOI: 10.22514/ejgo.2023.072
Do women's fatalistic tendencies affect their attitudes toward the early diagnosis of cervical cancer?
Do women's fatalistic tendencies affect their attitudes toward the early diagnosis of cervical cancer?
DOI: 10.22514/ejgo.2025.021
Prediction of HER2 status in breast cancer patients based on DCE-MRI imaging features combined Ki-67 and VEGF expression
Prediction of HER2 status in breast cancer patients based on DCE-MRI imaging features combined Ki-67 and VEGF expression
DOI: 10.22514/ejgo.2025.022
High performance of human papillomavirus 16/18/58 genotyping combined with cytology in the initial screening of cervical cancer in China
High performance of human papillomavirus 16/18/58 genotyping combined with cytology in the initial screening of cervical cancer in China
DOI: 10.22514/ejgo.2025.023
Isolated lymph node recurrence and prognosis in endometrioid type endometrial cancer
Isolated lymph node recurrence and prognosis in endometrioid type endometrial cancer
DOI: 10.22514/ejgo.2025.024
Efficacy of recombinant human interferon α-2b combined with cervical loop electrosurgical excision procedure in the treatment of cervical precancerous lesions
Efficacy of recombinant human interferon α-2b combined with cervical loop electrosurgical excision procedure in the treatment of cervical precancerous lesions
DOI: 10.22514/ejgo.2025.025
Knockdown of UBAP2L inhibits the growth and motility of endometrial cancer cells
Knockdown of UBAP2L inhibits the growth and motility of endometrial cancer cells
DOI: 10.22514/ejgo.2025.026
Ovarian cancer recurrence manifested as a solitary intraluminal mass in ileum
Ovarian cancer recurrence manifested as a solitary intraluminal mass in ileum
DOI: 10.22514/ejgo.2025.027
Published Ahead of Print
Expression and clinical significance of CSAD in type I endometrial carcinoma
Expression and clinical significance of CSAD in type I endometrial carcinoma
Online publish date: 28 October 2024
DOI: 10.22514/ejgo.2024.110
Special Issues
Quality of Life in Gynecologic Malignancies
Keywords: Quality of life; Palliative care; Symptom management
Editor: Lori Spoozak, MD
Submission deadline: 31 December 2024
Endometrial Cancer and Fertility Preservation in the Denatality ERA
Keywords: Endometrial cancer; Fertility preservation; Surgery fertility sparing; Ovarian reserve
Editor: Dr. Giuseppe Gullo, MD, PhD,Dr. Alessandra Lopez, MD,Dr. Valentina Billone, MD, PhD St.
Submission deadline: 31 December 2025
Advances in Ovarian Cancer Research
Keywords: Ovarian cancer; Cytoreductive surgery; Recurrent ovarian cancer; Retroperitoneal lymphadenectomy; Women cancer global variation
Editor: Basel Refky, MD
Submission deadline: 31 July 2025
Current Update in the Treatment of Cervical Cancer
Keywords: Radical hysterectomy; Fertility Sparing; Oncological Outcomes
Editor: Carlo Ronsini, MD
Submission deadline: 31 December 2024
Gynecological Cancer Prevention: A New Prospective
Keywords: Gynecology; Obstetric and Gynecological Ultrasound; Menopause Obstetrics; Gynecologic Oncology; Gynecologic Pathology
Editor: Ottavia Dʼoria, MD
Submission deadline: 31 October 2023
Molecular Pathological Approach to Uterine Mesenchymal Tumors and Malignant Tumors for the Establishment of New Diagnostic and Therapeutic Methods
Keywords: Leiomyoma; Leiomyosarcoma; Ovarian cancer; Cervical cancer; Endometrial cancer
Editor: Prof. Takuma Hayashi
Submission deadline: 31 October 2023
Molecular Characterization in Endometrial Cancer: Progress and Prospects
Keywords: Endometrial Cancer (EC); Molecular Biomarkers; Immune Checkpoint Inhibitor; Precision Medicine
Editor: Andrea Giannini, MD, PhD
Submission deadline: 31 December 2022
Immunotherapy for Gynecological Oncology
Keywords: Cancer immunotherapy;Cancer vaccination;Immune checkpoint inhibitor;Ovarian cancer;Cervical cancer;Endometrial cancer
Editor: Tadahiro Shoji, MD
Submission deadline: 31 July 2021
Enhanced Recovery of Gynecological Oncology
Keywords: Gynecological Cancer; Enhanced Recovery After Surgery; Minimally Invasive Surgery; Pain Management; Nutritional Support; High Quality Nursing; Psychological Counseling; Complication Management
Editor: Lin Li, MD
Submission deadline: 31 December 2022
Molecular Markers in Ovarian Cancer: Roles in Diagnosis, Prognostic Prediction, and Personalized Therapy
Keywords: Ovarian Cancer;Diagnosis;Prognosis;Treatment Response;Personalized Therapy;Platinum Resistance;Homologous Recombination Deficiency;Immunotherapy;Cytoreduction;Proteomics;Genomics;Prognostic Biomarkers;Diagnostic Biomarkers
Editor: Sharad Ghamande, MD,David Mysona, MD
Submission deadline: 30 March 2022
Featured Article
Real-world bevacizumab utilization and outcomes among women with ovarian cancer in Europe and the United States. DOI: 10.31083/j.ejgo4206181
To Be a Reviewer
If you would like to volunteer to review a manuscript for European Journal of Gynaecological Oncology journal, please click “Review for EJGO” below to register at our submission website or log in our Online Peer Review system. Your name, contact details, and expertise will be automatically added to our database of reviewers.
Review for EJGOJoin Editorial Board
You are welcome to join our editorial board. Our journal produces and issues editorial board certificates for editorial board members, and the journal website will display the names and personal websites of editorial board members to help enhance their scientific influence. Members of the editorial committee are entitled to 1 free publication (both editorial member’s or recommended paper) per year, and other articles over 2 can enjoy 30% discount of publishing fee.
Join Editorial BoardEditor-in-Chief
Prof. Enrique Hernandez, MD, FACOG, FACS.
Dr. Hernandez is the J. Robert Willson Professor and Chair, Obstetrics, Gynecology and Reproductive Sciences of Lewis Katz School of Medicine at Temple University. He is also a professor in Pathology and Laboratory Medicine of Lewis Katz School of Medicine at Temple University. He specializes in comprehensive, compassionate care of women with gynecologic cancer and pre-cancerous conditions, using the most up-to-date and sophisticated diagnostic and treatment tools.